Journal
/
/
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
JoVE Journal
Chemistry
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Chemistry
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
DOI:

10:44 min

May 15, 2019

, , , , ,

Chapters

  • 00:04Title
  • 00:52Preparation of Proteolysis-targeting Chimera (PROTAC) Homodimer 8 (Compound 8)
  • 04:32Preparation of tert-Butyl N-(1-Methyl-2,6-dioxo-3-piperidyl)carbamate (Building Block 2 for Heterodimer 9)
  • 05:52Functional Validation of PROTAC Compounds
  • 08:12Results: Characterization and Efficacy of PROTACs
  • 09:52Conclusion

Summary

Automatic Translation

This work describes the synthesis and characterization of a pomalidomide-based, bifunctional homo-PROTAC as a novel approach to induce ubiquitination and degradation of the E3 ubiquitin ligase cereblon (CRBN), the target of thalidomide analogs.

Related Videos

Read Article